To further investigate the possible link between COX-2 levels and the progression of CAVD, we compared COX-2 levels with the levels of α-smooth muscle actin (SMA) in CAVD and control AVs. The gene discussed is SMN1; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.